Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy

Ovarian cancer accounts for >140 000 deaths globally each year. Typically, disease is asymptomatic until an advanced, incurable stage. Although response to cytotoxic chemotherapy is frequently observed, resistance to conventional platinum-based therapies develop rapidly. Improved treatments are t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Gene Ther
Main Authors: Hulin-Curtis, S L, Uusi-Kerttula, H, Jones, R, Hanna, L, Chester, J D, Parker, A L
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4947523/
https://ncbi.nlm.nih.gov/pubmed/27229159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2016.22
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados